Palvella Therapeutics (PVLA) Shares Outstanding (2013 - 2026)

Palvella Therapeutics (PVLA) has reported Shares Outstanding (Entity) for 14 consecutive years, with $14.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 29.87% year-over-year to $14.3 million; the TTM figure through Mar 2026 stood at $14.3 million (up 29.87% YoY), while the FY2025 annual figure was $12.4 million, up 456.21% from the prior year.
• Shares Outstanding (Entity) advanced to $14.3 million in Q1 2026 per PVLA's latest filing, from $12.4 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $14.3 million in Q1 2026 and bottomed at $926225.0 in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $4.4 million across 5 years, with a median of $1.2 million in 2023.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) advanced 0.57% — and 2025, when it soared 790.98%.
• Palvella Therapeutics' Shares Outstanding (Entity) stood at $931488.0 in 2022, then surged by 32.8% to $1.2 million in 2023, then surged by 79.95% to $2.2 million in 2024, then jumped by 456.21% to $12.4 million in 2025, then grew by 15.61% to $14.3 million in 2026.
• Business Quant data shows PVLA's Shares Outstanding (Entity) at $14.3 million in Q1 2026, $12.4 million in Q4 2025, and $11.1 million in Q3 2025.